Related Experiment Video
Updated: May 24, 2026
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Identification of novel HLA-A(*)0201-restricted CTL epitopes from Pokemon
Bangqing Yuan1, Lin Zhao, Ronghua Xian
1Department of Neurosurgery, The 476th Hospital of Fuzhou General Hospital, Fuzhou, Fujian 350025, China.
Abstract:
Pokemon is a member of the POK family of transcriptional repressors and aberrant overexpressed in various human cancers. Therefore, the related peptide epitopes derived from Pokemon is essential for the development of specific immunotherapy of malignant tumors. In this study, we predicted and identified HLA-A(*)0201-restricted cytotoxic T lymphocyte (CTL) epitopes derived from Pokemon with computer-based epitope prediction, peptide-binding assay and testing of the induced CTLs toward different kinds of carcinoma cells. The results demonstrated that effectors induced by peptides of Pokemon containing residues 32-40, 61-69, 87-95, and 319-327 could specifically secrete IFN-γ and lyse tumor cell lines of Pokemon-positive and HLA-A2-matched. The results suggest that Pokemon32, Pokemon61, Pokemon87, and Pokemon319 peptides are novel HLA-A(*)0201-restricted restricted CTL epitopes, and could be utilized in the cancer immunotherapy against a broad spectrum of tumors.
Insights
New research identifies Pokemon-derived peptides as potential targets for cancer immunotherapy. These specific epitopes can stimulate cytotoxic T lymphocytes (CTLs) to recognize and attack cancer cells, offering a promising avenue for treating various malignancies.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Pokemon, a transcriptional repressor, is overexpressed in human cancers.
- Targeting Pokemon offers a potential strategy for cancer immunotherapy.
- Identifying specific Pokemon-derived epitopes is crucial for developing targeted therapies.
Purpose of the Study:
- To predict and identify HLA-A(*)0201-restricted cytotoxic T lymphocyte (CTL) epitopes from Pokemon.
- To evaluate the immunotherapeutic potential of these identified epitopes against carcinoma cells.
Main Methods:
- Computational epitope prediction.
- Peptide-binding assays.
- Assessment of induced CTL activity against tumor cell lines.
Main Results:
- Four Pokemon peptides (residues 32-40, 61-69, 87-95, 319-327) were identified as HLA-A(*)0201-restricted CTL epitopes.
- These peptides induced CTLs that specifically secreted IFN-γ and lysed Pokemon-positive, HLA-A2-matched carcinoma cells.
- Pokemon32, Pokemon61, Pokemon87, and Pokemon319 peptides demonstrated significant anti-tumor activity.
Conclusions:
- Pokemon-derived peptides Pokemon32, Pokemon61, Pokemon87, and Pokemon319 are novel HLA-A(*)0201-restricted CTL epitopes.
- These epitopes hold potential for developing effective cancer immunotherapies.
- The findings suggest a broad applicability against various Pokemon-expressing tumors.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
13:10In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
Published on: August 1, 2014
